Jeffrey A Rona insider trades: Ovid Therapeutics (OVID) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | OVID | ↓ Sell | 8,541 | $1.45 | $12K | Direct | Mar 2, 2026 (7d) |
| Feb 26, 2025 | OVID | ↓ Sell | 3,902 | $0.56 | $2K | Direct | Feb 28, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OVID insiders
Open-market trades in the last 12 months
About Jeffrey A Rona's insider trades
Jeffrey A Rona is Cbfo at Ovid Therapeutics (OVID). Since Feb 26, 2025, Jeffrey has reported no open-market purchases and 2 sales worth $15K on SEC Form 4. In the last 12 months: 1 sale ($12K).
Their filings also include grants and awards (14 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OVID insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.